|
ZeOmega and Clearlink Partners Unite to Streamline Delegated Clinical Services
Friday, August 22, 2025
New partnership powers faster, more compliant, and member-centered care for Care Management, Utilization Management, and more
PLANO, Texas, Aug. 14, 2025 /PRNewswire/ -- ZeOmega(®), the leading population health management organization, today announced a strategic partnership with Clearlink Partners, a nationally recognized managed care consultancy, to deliver a comprehensive, unified solution for delegated clinical services. The combined solution brings together ZeOmega's Jiva((TM)) platform with Clearlink's deep operational and clinical expertise, offering payers a scalable way to manage key functions like Utilization Management (UM), Care Management (CM), and Appeals & Grievances (A&G) with greater speed, compliance, and transparency.
As value-based care expands and regulatory scrutiny intensifies, many health plans are turning to third-party partners to manage core clinical and administrative functions. However, this delegation can introduce new complexity - especially when plans rely on multiple vendors with siloed systems, leading to delays, compliance gaps, and inconsistent member experiences.
By streamlining the full scope of delegated clinical services, ZeOmega and Clearlink eliminate these hurdles - integrating people, processes, and technology into a single, coordinated framework that enables faster decisions, more efficient workflows, real-time insights, and improved outcomes.
Additional benefits include:
-- A highly configurable platform tailored to each health plan's needs
-- Seamless documentation and real-time coordination across
interdisciplinary teams
-- Advanced analytics, intuitive dashboards, and performance benchmarking
for continuous improvement
-- Built-in audit-readiness, supported by Clearlink's experienced team and
best practice protocols
"The ZeOmega platform has been instrumental in enabling the rapid and successful launch of our Utilization Management and Care Management operations," said Sandy Spitale, MBA, BSN, RN, Chief Clinical Officer at Ochsner Health Plan. "Through our delegation to Clearlink Partners, who utilize ZeOmega's Jiva platform, we've achieved seamless documentation, streamlined workflows, and enhanced portal functionality. This infrastructure has empowered our team to effectively manage our Medicare Advantage population with greater efficiency, compliance, and member-centered care."
Clearlink evaluated multiple platform partners before selecting ZeOmega. According to Christina Turner, Partner and EVP of Solution Delivery at Clearlink Partners, "ZeOmega stood out for its high level of compliance, out-of-the-box functionality, ease of customization, and collaborative approach. Together, we've implemented a robust foundation and we're continuing to evolve the solution to deliver even greater results for our clients."
"This partnership reflects ZeOmega's commitment to powering the future of delegated clinical services," said Andy Arends, Chief Growth Officer at ZeOmega. "Together, we're giving payers and provider-sponsored plans a smarter, faster way to scale compliant, high-performing, quality-assured clinical services."
About Clearlink Partners
Clearlink Partners is an industry-leading managed care consultancy, specializing in transformation of end-to-end clinical and operational management services and market expansion initiatives for Managed Medicaid, Medicare Advantage, Special Needs Plans, complex care populations, and risk-adjusted entities. Headquartered in Charleston, South Carolina, Clearlink supports organizations as they navigate a dynamic healthcare ecosystem transforming operations to manage risk, optimize healthcare spend, improve access, support compliance, accelerate outcomes and improve member experience,
About ZeOmega
ZeOmega empowers health plans and other risk-bearing organizations with the industry's leading technology for simplifying population health management. Clients using ZeOmega's Jiva Healthcare Enterprise Management Platform experience superior workflow and proven results due to exceptional integration capabilities, unmatched clinical content, and a powerful rules engine. With deep domain expertise and a comprehensive understanding of population health challenges, ZeOmega serves as a true partner for clients with personalized deployment and delivery models. By consistently exceeding customer expectations and project benchmarks, ZeOmega has earned a reputation for being proactive, reliable, and dedicated to improving the health of its clients' members. ZeOmega was named Best in KLAS for Payer Care Management Solutions in 2022, 2023, 2024, and 2025. Founded in 2001, ZeOmega is privately held and headquartered in Plano, Texas.
ZeOmega and Jiva are registered trademarks or trademarks of ZeOmega, Inc. or its subsidiaries in the United States and other countries. Other marks or brands may be claimed as the property of others.
View original content to download multimedia:https://www.prnewswire.com/news-releases/zeomega-and-clearlink-partners-unite-to-streamline-delegated-clinical-services-302529474.html
SOURCE ZeOmega
|
|
|
|
|
|
 |
Weekly Recap: 11 Tech Press Releases You Need to See | Jan 22, 2026
|
|
Sup AI Sets New Benchmark Record with 52.15% on Humanity's Last Exam | Jan 22, 2026
|
|
DEADLINE ANNOUNCED FOR 2026 NEW TOP-LEVEL DOMAIN APPLICATIONS | Jan 22, 2026
|
|
Trigent Partners with WeWork India to Expand its GCC Footprint | Jan 22, 2026
|
|
Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution | Jan 22, 2026
|
|
Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI | Jan 22, 2026
|
|
Exia Labs Brings Keystone to the U.S. Navy via DIU's Blue Object Management Challenge | Jan 22, 2026
|
|
Glasswall Brings Defense-Level File Sanitization to Every Government Agency and Business Using Microsoft 365 | Jan 22, 2026
|
|
Genpact Named a Leader in ISG Provider Lens(TM) 2025 for Insurance GCCs and Agentic AI Services | Jan 22, 2026
|
|
Buyers Edge Platform Appoints Jaime Selga to Lead Expansion Across the Middle East, Africa & Asia | Jan 22, 2026
|
|
|
|
